Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › MA › MARLBOROUGH › QUEST DIAGNOSTICS MASSACHUSETTS LLC

QUEST DIAGNOSTICS MASSACHUSETTS LLC

NPI: 1194062448 · MARLBOROUGH, MA 01752 · Clinical Medical Laboratory · NPI assigned 01/07/2013

$199.86M
Total Medicaid Paid
17,471,892
Total Claims
16,331,162
Beneficiaries
478
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBETZ, DAVID (DIRECTOR)
NPI Enumeration Date01/07/2013

Related Entities

Other providers sharing the same authorized official: BETZ, DAVID

ProviderCityStateTotal Paid
QUEST DIAGNOSTICS MASSACHUSETTS LLC EAST BOSTON MA $217K
QUEST DIAGNOSTICS MASSACHUSETTS LLC EAST BOSTON MA $32K
QUEST DIAGNOSTICS MASSACHUSETTS LLC BROCKTON MA $22K
QUEST DIAGNOSTICS MASSACHUSETTS LLC STOUGHTON MA $6K
QUEST DIAGNOSTICS MASSACHUSETTS LLC HYANNIS MA $3K
QUEST DIAGNOSTICS MASSACHUSETTS LLC WORCESTER MA $959.61
QUEST DIAGNOSTICS MASSACHUSETTS LLC WORCESTER MA $16.24

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,323,998 $27.08M
2019 2,366,965 $24.38M
2020 2,060,583 $26.75M
2021 2,578,702 $32.45M
2022 2,667,314 $30.53M
2023 2,847,953 $30.36M
2024 2,626,377 $28.30M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 364,457 341,701 $25.54M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 588,668 369,775 $21.23M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 616,440 430,388 $17.84M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 462,969 447,060 $8.57M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 467,507 452,416 $8.53M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 87,520 85,760 $4.61M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 6,544 6,527 $4.40M
86480 90,705 90,231 $3.69M
81513 69,030 67,405 $3.54M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 261,454 259,922 $3.53M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 132,599 132,418 $3.13M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 141,190 140,861 $3.10M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 257,262 254,120 $2.91M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 134,936 131,460 $2.67M
84443 Thyroid stimulating hormone (TSH) 438,719 431,980 $2.52M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 6,290 6,272 $2.46M
86003 34,974 31,707 $2.31M
80050 General health panel 191,679 190,440 $2.28M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 17,544 17,158 $2.26M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 102,108 95,354 $2.21M
83036 Hemoglobin; glycosylated (A1C) 524,358 517,748 $2.18M
87522 Neg quan hep c or qual rna 65,554 64,213 $2.18M
80061 Lipid panel 756,066 747,418 $2.01M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 711,137 660,744 $2.00M
87086 Culture, bacterial; quantitative colony count, urine 396,008 375,146 $1.90M
80053 Comprehensive metabolic panel 713,751 686,139 $1.90M
88305 Level IV - Surgical pathology, gross and microscopic examination 50,904 35,884 $1.89M
87799 48,763 21,560 $1.84M
83013 32,022 31,845 $1.60M
86803 211,957 209,915 $1.58M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 4,476 4,386 $1.37M
87536 31,504 30,982 $1.35M
87902 10,394 10,196 $1.29M
83655 153,172 152,513 $1.27M
87088 307,975 293,086 $1.13M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 22,400 21,627 $1.08M
82728 177,583 174,357 $1.02M
82607 173,925 172,068 $939K
85027 330,523 322,835 $909K
ATP17 172,315 171,810 $876K
88142 47,733 47,440 $862K
87070 133,815 130,897 $857K
80074 29,968 29,749 $801K
80048 Basic metabolic panel (calcium, ionized) 275,571 262,163 $718K
87340 124,986 123,667 $683K
86780 71,280 70,824 $670K
87512 20,044 19,734 $628K
82746 115,988 114,817 $628K
87481 22,845 11,056 $603K
87186 136,292 129,362 $602K
87081 115,929 113,430 $602K
ATP03 119,932 119,483 $593K
84153 82,774 81,707 $578K
84403 40,893 40,099 $565K
84702 54,214 45,097 $560K
84439 137,026 134,688 $553K
86317 59,667 57,345 $544K
81329 5,111 5,090 $526K
83550 157,063 154,252 $525K
87077 153,579 147,763 $514K
81001 264,250 254,573 $476K
80081 6,744 6,732 $475K
ATP14 180,990 174,033 $447K
82043 158,917 156,970 $446K
86592 162,380 160,409 $443K
86235 12,192 11,636 $429K
87650 23,315 22,976 $427K
83540 165,497 162,439 $410K
87631 4,150 4,107 $408K
86704 53,554 53,081 $407K
87510 23,077 22,474 $385K
87660 23,046 22,431 $381K
87480 23,101 22,500 $380K
82670 26,286 25,867 $363K
88141 21,786 21,695 $360K
83970 32,761 32,313 $357K
86787 44,613 44,275 $352K
82570 179,085 173,247 $352K
84146 38,723 38,126 $348K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,084 1,060 $344K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 7,386 6,068 $340K
86618 41,050 40,556 $336K
82105 30,192 29,876 $329K
82274 26,520 26,371 $309K
86762 39,868 39,533 $297K
88112 17,876 11,047 $291K
83001 29,660 29,386 $288K
87517 9,771 9,552 $287K
86708 38,302 38,023 $280K
88342 5,375 4,112 $278K
86038 50,489 49,941 $273K
86140 90,152 84,918 $273K
82784 40,667 40,069 $270K
83735 97,158 79,170 $262K
82652 12,489 12,351 $261K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1,933 1,920 $251K
83516 29,798 22,393 $247K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 14,519 7,391 $244K
83880 17,988 16,938 $243K
86696 19,539 19,334 $233K
82785 20,031 19,916 $228K
83002 23,079 22,885 $222K
86706 38,014 37,687 $208K
80076 84,042 81,881 $203K
86735 24,239 24,056 $200K
86769 7,005 6,920 $200K
85610 112,797 73,241 $197K
84402 12,044 11,901 $193K
86361 17,360 17,217 $191K
80055 10,703 10,586 $190K
86665 9,195 8,921 $187K
81511 890 889 $179K
84481 26,005 25,625 $170K
86376 20,659 20,480 $170K
86008 6,516 6,062 $169K
88341 3,249 2,362 $169K
ATP11 34,542 34,391 $169K
86765 24,592 24,429 $166K
ATP15 38,659 35,334 $166K
84460 101,187 95,107 $162K
86617 10,555 10,237 $161K
82627 12,736 12,637 $158K
86695 19,008 18,804 $158K
85652 100,332 96,319 $157K
87147 33,902 33,469 $155K
86200 19,105 19,005 $154K
87209 17,171 14,406 $153K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 77,367 53,366 $150K
83020 15,676 15,535 $150K
87901 1,239 1,219 $149K
ATP08 86,774 82,988 $147K
82248 92,475 88,194 $147K
88312 3,222 2,750 $146K
ATP18 28,245 28,175 $143K
87338 13,606 13,533 $134K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,292 5,227 $131K
84450 88,381 82,409 $130K
86360 7,781 7,657 $129K
87255 6,701 6,642 $129K
87625 7,704 7,690 $127K
83721 36,652 36,307 $127K
82950 32,366 32,129 $125K
86364 16,065 15,985 $123K
86850 24,787 24,521 $119K
86666 5,325 4,648 $117K
83021 8,959 8,933 $116K
84270 9,159 9,004 $113K
82533 13,815 13,087 $112K
80164 25,180 24,313 $111K
86800 14,852 14,704 $110K
ATP04 19,550 19,387 $110K
83690 32,063 31,078 $109K
84436 37,110 36,640 $106K
88304 4,409 3,694 $96K
86160 8,610 8,260 $95K
87469 3,740 3,721 $95K
84144 7,742 7,435 $94K
81596 3,086 3,072 $94K
82150 23,438 21,964 $92K
84703 15,968 15,657 $92K
87427 12,146 12,000 $91K
87900 1,239 1,219 $90K
87468 3,731 3,718 $89K
86753 9,221 6,995 $89K
82565 70,809 67,103 $88K
80197 23,550 13,332 $87K
86664 8,318 8,226 $84K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 820 756 $82K
86431 29,598 29,355 $82K
87449 12,645 11,509 $82K
84479 29,841 29,510 $81K
84480 14,827 14,599 $81K
86039 13,438 13,293 $81K
87484 2,963 2,956 $80K
86147 4,848 2,879 $79K
83520 10,111 7,753 $78K
82977 26,063 25,715 $76K
87177 17,188 14,426 $75K
82951 6,423 6,416 $75K
ATP10 18,471 17,612 $73K
86225 11,592 11,481 $73K
87329 9,963 9,786 $73K
84445 2,697 2,667 $72K
83525 12,114 11,978 $72K
80178 23,400 22,065 $71K
86901 28,042 27,710 $70K
87497 4,148 2,051 $70K
86900 28,060 27,727 $70K
85018 61,996 61,116 $69K
87529 2,286 1,369 $68K
87045 13,247 13,037 $68K
81401 424 424 $67K
80159 17,371 14,813 $65K
86141 9,778 9,649 $64K
82550 34,288 32,390 $64K
85014 57,987 57,183 $64K
83718 20,096 19,956 $63K
83090 6,805 6,760 $63K
36415 Collection of venous blood by venipuncture 749,480 665,936 $62K
83498 2,691 2,678 $62K
87075 12,754 12,446 $61K
86334 9,028 8,884 $61K
84100 45,351 34,946 $61K
85730 17,723 17,297 $59K
82677 3,155 3,144 $59K
ATP07 26,301 25,914 $58K
84550 42,797 41,886 $57K
82024 3,613 3,481 $57K
86146 2,961 1,727 $57K
ATP13 11,633 10,928 $56K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 1,095 1,058 $56K
82947 35,660 34,483 $56K
84425 6,969 6,925 $54K
82465 26,554 26,347 $52K
84154 9,563 9,438 $51K
84165 15,084 14,857 $50K
87324 8,052 7,911 $48K
ATP02 17,166 16,795 $48K
86705 6,348 6,299 $47K
83921 7,929 7,871 $47K
86336 3,158 3,146 $46K
87046 8,026 7,498 $45K
ATP05 7,983 7,863 $44K
87563 1,566 1,554 $44K
84681 4,796 4,743 $42K
84156 28,985 25,920 $42K
86709 5,652 5,619 $42K
84134 7,847 6,111 $41K
80069 20,558 15,505 $40K
85379 5,637 5,560 $40K
81015 24,967 24,268 $39K
84520 44,051 41,061 $38K
87205 18,133 17,601 $37K
86021 4,621 4,052 $37K
82088 1,997 1,943 $37K
86255 7,155 5,102 $37K
82542 2,413 2,187 $37K
85004 23,084 19,387 $36K
84484 4,864 4,566 $36K
81025 6,929 6,544 $35K
ATP06 6,689 6,601 $35K
ATP09 11,180 10,425 $34K
87040 4,300 3,578 $34K
82747 5,614 5,576 $33K
81508 392 392 $32K
81003 25,057 24,187 $32K
80051 21,435 19,826 $31K
82330 6,519 6,342 $31K
ATP16 7,177 5,592 $31K
82955 3,913 3,903 $30K
87906 403 397 $30K
82040 20,206 19,326 $30K
82247 21,655 16,475 $30K
83014 4,815 4,782 $29K
82390 5,084 5,042 $29K
82172 2,585 2,557 $29K
82378 4,162 3,871 $29K
80047 5,549 5,188 $28K
84432 3,530 3,464 $28K
87150 1,312 1,308 $27K
84075 20,228 16,274 $26K
86663 2,763 2,737 $26K
86777 2,759 2,741 $26K
86778 2,215 2,202 $26K
85246 1,353 1,348 $26K
86645 2,297 2,255 $26K
84207 2,390 2,374 $26K
85045 12,206 11,926 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 493 484 $25K
86308 5,855 5,811 $24K
82787 2,641 2,198 $24K
83010 3,771 3,695 $24K
86258 2,595 2,581 $24K
86304 2,077 2,032 $24K
81243 500 496 $24K
86341 1,480 1,257 $23K
82103 3,604 3,570 $23K
87350 3,127 3,097 $23K
83615 11,595 11,076 $23K
86812 1,246 1,237 $22K
86481 359 357 $22K
86747 1,128 1,117 $22K
84155 16,838 16,434 $22K
84244 2,102 2,078 $21K
84305 1,989 1,975 $21K
84630 3,183 3,107 $21K
87493 2,994 2,962 $21K
82310 16,621 16,089 $20K
86593 9,631 9,385 $20K
86870 839 810 $19K
86644 2,161 2,116 $19K
82952 5,844 5,840 $19K
86359 1,928 1,900 $19K
ATP12 4,485 4,378 $19K
85007 11,816 11,464 $19K
85041 10,332 10,218 $19K
80177 4,992 4,878 $18K
87106 2,914 2,873 $18K
83883 3,251 2,353 $18K
83521 1,974 1,912 $17K
82668 2,145 2,102 $17K
87102 2,825 2,768 $17K
85048 24,601 20,710 $16K
85060 1,359 1,320 $16K
84590 3,104 3,094 $16K
80202 2,537 1,231 $15K
84163 1,043 996 $15K
87999 303 300 $15K
80156 5,128 5,003 $15K
86300 1,574 1,458 $14K
80175 3,838 3,769 $14K
83835 1,836 1,730 $14K
87101 2,676 2,645 $14K
82530 1,514 1,358 $14K
86707 1,984 1,959 $14K
84466 2,524 2,481 $13K
80299 2,375 2,250 $13K
81512 59 58 $13K
86381 1,720 1,711 $12K
80185 4,130 3,760 $12K
82672 753 740 $12K
85245 627 625 $12K
84132 9,260 8,777 $12K
84478 8,528 6,300 $12K
85613 2,209 2,192 $12K
ATP19 2,922 2,905 $11K
84482 1,086 1,075 $11K
82140 1,853 1,749 $11K
84166 2,145 2,128 $11K
82985 3,215 3,148 $11K
83704 721 707 $10K
86162 964 960 $10K
82525 1,392 1,365 $10K
87140 1,909 1,667 $10K
80165 1,793 1,759 $10K
83698 336 335 $10K
86335 1,229 1,216 $10K
87076 1,917 1,885 $9K
83519 1,762 1,229 $9K
83993 2,149 2,135 $9K
89055 3,636 3,570 $9K
85240 567 564 $8K
86702 1,739 1,675 $8K
83695 1,282 1,267 $8K
81241 276 273 $8K
80158 1,064 613 $8K
86060 1,441 1,433 $8K
86301 823 776 $7K
82164 1,109 1,097 $7K
85660 1,616 1,604 $7K
82107 198 197 $7K
88307 35 25 $7K
87254 317 315 $7K
87280 609 603 $7K
86036 1,544 1,527 $7K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 8,345 8,316 $7K
86015 1,798 1,792 $7K
84446 1,301 1,298 $6K
87535 267 262 $6K
80183 1,395 1,377 $6K
86682 484 449 $6K
83935 2,535 2,451 $6K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) 4,193 4,187 $6K
87328 742 735 $6K
82085 1,360 1,347 $6K
86337 528 527 $6K
87220 2,088 2,059 $6K
84300 3,050 2,971 $6K
86701 1,734 1,671 $6K
80162 1,513 1,457 $6K
82166 155 155 $5K
87634 47 47 $5K
83930 2,074 2,030 $5K
84295 4,929 4,527 $5K
80184 1,910 1,859 $5K
83876 148 146 $5K
87206 1,553 1,438 $5K
82553 771 754 $4K
87478 242 238 $4K
87276 383 382 $4K
82653 407 404 $4K
87275 384 382 $4K
86355 349 349 $4K
88185 12 12 $4K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 12,041 12,001 $4K
82340 1,213 1,204 $4K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous 1,449 1,443 $3K
87581 111 111 $3K
85306 338 334 $3K
86886 651 625 $3K
82610 504 483 $3K
86357 312 312 $3K
84182 41 41 $3K
86148 215 144 $3K
84080 884 875 $3K
87207 817 797 $3K
85049 1,329 1,314 $2K
82384 198 194 $2K
81256 99 96 $2K
89051 772 741 $2K
85303 284 283 $2K
84140 140 139 $2K
88313 54 47 $2K
82435 2,991 2,789 $2K
82397 225 217 $2K
82374 2,809 2,605 $2K
86885 373 366 $2K
86774 254 254 $2K
89060 543 525 $2K
87107 212 208 $2K
85247 78 78 $2K
87185 453 443 $2K
82232 249 245 $1K
86231 224 223 $1K
85300 191 190 $1K
82705 652 645 $1K
86001 72 72 $1K
81240 59 59 $1K
88262 12 12 $1K
86382 40 40 $1K
83630 82 80 $1K
86256 215 214 $1K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 22 22 $1K
80195 461 297 $1K
88230 12 12 $1K
82523 365 359 $1K
80186 312 298 $1K
87521 Neg quan hep c or qual rna 61 61 $971.92
86611 42 40 $920.38
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 976 972 $853.02
88302 34 31 $837.08
87272 102 100 $819.45
80201 220 219 $802.88
86628 24 24 $800.07
81257 12 12 $797.81
85651 261 251 $752.54
84378 193 193 $735.13
84133 325 323 $700.49
82552 104 102 $687.75
88189 12 12 $684.42
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision 3,271 3,261 $682.09
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 85 85 $651.79
87486 21 21 $570.75
88184 12 12 $570.31
82157 26 26 $550.94
80198 81 76 $523.90
83789 90 82 $320.56
82180 49 49 $313.37
86790 61 38 $303.05
84252 24 24 $290.71
83003 28 28 $278.48
85598 25 25 $263.20
G0475 Hiv antigen/antibody, combination assay, screening 1,632 1,631 $251.05
ATP20 169 169 $236.45
80203 77 75 $218.63
86738 25 25 $215.76
86648 25 25 $207.10
86340 28 28 $195.03
80171 37 37 $189.03
99001 2,529 1,555 $173.59
82626 13 13 $163.59
80235 12 12 $136.24
86215 12 12 $130.56
86161 12 12 $121.78
87015 25 25 $118.57
85597 28 28 $113.23
86880 40 40 $99.06
84238 26 26 $96.91
82104 26 25 $88.73
84560 26 26 $71.93
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) 1,169 1,163 $59.11
82656 25 25 $57.76
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count 943 933 $55.81
82365 12 12 $55.30
86316 13 13 $55.05
80173 12 12 $21.39
36416 848 550 $0.59
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test 276 267 $0.00